Clive S. Zent, M.D.

Clive S. Zent, M.D.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 704
Rochester, NY 14642

Office: (585) 273-3258
Administrative: (585) 273-3258
Fax: (585) 276-0350

Journal Articles

Showing all 120 journal articles available.

2014 Nov
Conte MJ; Bowe DA; Wiseman GA; Rabe KG; Slager SL; Schwager SM; Call TG; Viswanatha DS; Zent CS. "Use of positron emission tomography-computerized tomography (PET-CT) in the management of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL)". Leuk Lymphoma. 2014; : Epub Feb 17.
2014
Baig NA; Taylor RP; Lindorfer MA; Church AK; Laplant BR; Pettinger AM; Shanafelt TD; Nowakowski GS; Zent CS. "Induced resistance to ofatumumab-mediated cell clearance mechanisms, including complement-dependent cytotoxicity, in chronic lymphocytic lekemia". J Immunol. 2014; 192(4): 1620-29.
2014
Call TG; Norman AD; Hanson CA; Achenbach SJ; Kay NE; Zent CS; Ding W; Cerhan JR; Rabe KG; Vachon CM; Hallberg EJ; Shanafelt TD; Slager SL. "Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphomphocytosis using the 2008 guidelines". Cancer. 2014; Epub April 7.
2014
Barr PM; Zent CS. "Infection in chronic lymphocytic leukemia: Parsimony has it's limits". Leuk Lymphoma. 2014; Epub April 25.
2014
Bowen DA; Rabe KG; Schwager SM; Slager SL; Call TG Viswanatha DS; Zent CS. "Infectious Lymphadenitis in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma: A rare, but important, complication". Leuk Lymphoma. 2014; Epub April 17.
2014
Zent CS; Taylor RP; Lindorfer MA; Beum PV; Laplant B; Wu W; Call TG; Bowen DA; Conte MJ; Frederick LA, Link BK; Blackwell SE; Veeramani S; Baig NA; Viswanatha DS; Weiner GJ; Witzig TE. "Chemoimmunotherapy for relapsed/refreactory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cells". Am J Hematol. 2014; Epub April 10.
2013 Nov
Shanafelt, T; Lanasa, MC; Call, TG; Beaven, AW; Leis, JF; LaPlant, B; Bowen, D; Conte, M; Jelinek, DF; Hanson, CA; Kay, NE; Zent, CS. "Ofatumumab-based chemoimmunotherapy is effective and well tolerated in patients with previously untreated chronic lymphocytic leukemia (CLL)". Cancer. 2013; 119(21): 3788-96.
2013 Nov
Greipp, PT; Smoley, SA; Viswanatha, DS; Frederick, LS; Rabe, KG; Sharma, RG; Slager, SL; Van Dyke, DL; Shanafelt, TD; Tschumper, RC; Zent, CS. "Patients with chronic lymphocytic leukaemia and clonal deletion of both 17p13.1 and 11q22.3 have a very poor prognosis". Br J Haematol. 2013; 163(3): 326-33.
2013 Nov
Barr, PM; Zent, CS. "The ABC of CLL: Etiology of cytopenias is important in staging and management". Leuk Lymphoma. 2013; Epub Nov 1.
2013 Sep
Charbonneau B; Wang AH; Maurer MJ; Asmann YW; Zent CS; Link BK; Ansell SM; Weiner GJ; Ozsan N; Feldman AL; Witzig TE; Cunningham JM; Dogan A; Habermann TM; Slager SL; Novak AJ; Cerhan JR. "CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis". Cancer Immunol Immunother. 2013; 62(9): 1475-84.
2013 Sep
Parikh SA; Rabe KG; Call TG; Zent CS; Habermann TM; Ding W; Leis JF; Schwager SM; Hanson CA; Macon WR; Kay NE; Slager SL; Shanafelt TD. "Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients." Br J Haematol. 2013; 162(6): 774-82.
2013 Mar
Zent, CS; Wu, W; Bowen, DA; Hanson, CA; Pettinger, AM; Shanafelt, TD; Kay, NE; Leis, JF; Call, TG. "Addition of granulocyte macrophage colony stimulating factor does not improve response to early treatment of high-risk chronic lymphpocytic leukemia with alemtuzumab and rituximab". Leuk Lymphoma. 2013; 54(3): 476-82.
2013 Jan
Shanafelt, TD; Call, TG; Zent, CS; Leis, JF; LaPlant, B; Bowen, DA; Roos, M; Laumann, K; Ghosh, AK; Lesnick, C; Lee, MJ; Yang, CS; Jelinek, DF; Erlichman, C; Kay, NE. "Phase 2 trial of daily, oral polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphpocytic leukemia". Cancer. 2013; 119(2): 363-70.
2013
Shanafelt TD; Ramsay AG; Zent CS; Leis JF; Tun HW; Call TG; LaPlant B; Bowen D; Pettinger A; Jelinek DF; Hanson CA; Kay NE. "Long-term repair of T-cell synapse activity in a phase 2 trial of chemoimmunotherapy followed by lenalidomide consolidation in previously untreated chronic lymphocytic leukemia". Blood. 2013; 121: 4137-41.
2013
Kourelis TV; Gertz M; Zent C; Lacy M; Kyle R; Kapoor P; Zeldenrust S; Buadi F; Witzig T; Hayman S; Lust J; Russell S; Lin Y; Rajkumar VS; Kumar S; Leung N; Dingli D; Dispenzieri A. "Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphoma". Am J Hematol. 2013; 88: 375-8.
2013
Witzig TE; Wiseman GA; Maurer MJ; Habermann TM; Micallef IN; Nowakowski GS; Ansell SM; Colgan JP; Inwqards DJ; Porrata LF; Link BK; Zent CS; Johnston PB; Shanafelt TD; Allmer C; Asmann YW; Gupta M; Ballas ZK; Smith BJ; Weiner GJ. "A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma". Am J Hematol. 2013; 88(7): 589-593.
2013
Gonsalves WI; Zent CS; Pulido JS; Patnaik MM. "Visual loss in early-stage chronic lymphocytic leukemia". J Clin Oncol. 2013; 31(17): e280-2.
2013
Slager, SL; Zent, CS. "Genetic risk of chronioc lymphocytic leukemia: A tale of two cities". Leuk Lymphoma. 2013; 55(4): 735-736.
2012 Nov
Baig NA; Taylor RP; Lindorfer MA; Church AK; LaPlant Br; Pavey ES; Nowakowski GS; Zent CS. "Complement dependent cytotoxicity in chronic lymphocytic leukemia: ofatumumab enhances alemtuzumab complement dependent cytotoxicity and reveals cells resistant to activated complement". Leuk Lymphoma. 2012; 53(11): 2218-27.
2012 Sep
Charbonneau B; Maurer MJ; Fredericksen ZS; Zent CS; Link BK; Novak AJ; Ansell SM; WeinerGJ; Wang AH; Witzig TE; Dogan A; Slager SL; Habermann TM; Cerhan JR. "Germline variation in complement genes and event-free survival in follicular and diffuse large B-cell lymphoma". Am J Hematol. 2012; 87(9): 880-5.
2012 Aug
Taylor RP; Lindorfer MA; Zent CS. "Anti-CD20 antibody therapy for B-cell lymphomas". N Engl J Med. 2012; 367(9): 876-7.
2012 Apr
Shanafelt TD; Kay NE; Rabe KG; Inwards DJ; Zent CS; Leis JF; Schwager SM; Thompson CA; Bowen DA; Witzig TE; Slager SL; Call TG. "Hematologist/oncologist disease-specific expertise and survival: lessions from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)". Cancer. 2012; 118(7): 1827-37.
2012 Mar
Gustafson MP; Abraham RS; Lin Y; Wu W; Gastineau DA; Zent CS; Dietz AB. "Association of an increased frequency of CD14+ HLA-DR lo/neg monocytes with decreased time to progression in chronic lymphocytic leukaemia (CLL)". Br J Haematol. 2012; 156(5): 674-6.
2012 Feb
Zent CS; Smith BJ; Ballas ZK; Wooldridge JE; Link BK; Call TG; Shanafelt; TD; Bowen DA; Kay NE; Witzig TE; Weinier GJ. "Phase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemia". Leuk Lymphoma. 2012; 53(2): 211-7.
2012 Feb
Shanafelt TD; Kay NE; Rabe KG; Call TG; Zent CS; Schwager SM; Leis JF; Jelinek DF; Slager SL; Hanson CA. "Survival of patients with clinically identified monoclonal B-cell lymphocytosis (MBL) relative to the age- and sex-matched general population". Leukemia. 2012; 26(2): 373-6.
2012
Lindorfer MA; Wiestner A; Zent CS; Taylor RP. "Monoclonal antibody (mAb)-based cancer therapy: Is it time to reevaluate dosing strategies?". Oncoimmunology. 2012; 1(6): 959-61.
2012
Zent CS. "Improving quality of life in chronic lymphocytic leukemia". Leuk Lymphoma. 2012; 53(7): 1247-8.
2011 Oct
Zent CS. "Multi-parameter prognostication in chronic lymphocytic leukemia". Leuk Lymphoma. 2011; 52(10): 1823-4.
2011 Oct
Mraz M; Zent CS; Church AK; Jelinek DF; Wu X. "Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin alpha-4-beta-1 (VLA-4) with natalizumab can overcome this resistance". Br J Haematol. 2011; 155(1): 53-64.
2011 Sep
Maurer MJ; Cerhan JR; Katzmann JA; Link BK; Allmer C; Zent CS; Call TG; Rabe KG; Hanson CA; Kay NE; Slager SL; Witzig TE; Shanafelt TD. "Monoclonal and polyclonal serum free light chains and clinical outcome in chronic lymphocytic leukemia". Blood. 2011; 118(10): 2821-6.
2011 Aug
Zent CS; Kay NE. "Management of patients with chronic lymphocytic leukemia with a high risk of adverse outcome: the Mayo Clinic approach". Leuk Lymphoma. 2011; 52(8): 1425-34.
2011 Jul
Chen D; Kettering RP; Hanson CA; Colgan JP; Zent CS; Viswanatha DS. "A case of hairy cell leukemia with CCND1-IGH translocation: indolent non-nodal mantle cell lymphoma revisited". Am J Surg Pathol. 2011; 35(7): 1080-4.
2011 Jun
Zent CS; Polliack A; Tadmor T. "FISHing for answers in proliferation centers of chronic lymphocytic leukemia lymph nodes". Leuk Lymphoma. 2011; 52(6): 946-7.
2011 Feb
Shanafelt TD; Drake MT; Maurer MJ; Allmer C; Rabe KG; Slager SL; Weiner GH; Call TG; Link BK; Zent CS; Kay NE; Hanson CA; Witzig TE; Cerhan JR. "Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia". Blood. 2011; 117(5): 1492-8.
2011
Gutierrez A; Arendt BK; Tschumper RC; Kay NE; Zent CS; Jelinek DF. "Differentiation of chronic lymphocytic leukemia B-cells into immunoglobulin secreting cells decreases LEF-1 expression". PLoS One. 2011; 6(10): e26056.
2010 Dec
Shanafelt T; Zent C; Byrd J; Erlichman C; LaPlant B; Ghosh A; Call T; Villalona-Calero M; Jelinek D; Bowen D; Laumann K; Wu W; Hanson C; Kay N. "Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemia". Leuk Lymphoma. 2010; 51(12): 2222-9.
2010 Oct
Zent CS. "Cell-mediated immunity in chronic lymphocytic leukemia". Leuk Lymphoma. 2010; 51(10): 1775-6.
2010 Oct
Shanafelt TD; Rabe KG; Kay NE; Zent CS; Jelinek DF; Reinalda MS; Schwager SM; Bowen DA; Slager SL; Hanson CA; Call TG. "Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia". Cancer. 2010; 116(20): 4777-87.
2010 Sep
Jevremovic D; Dronca RS; Morice WG; McPhail ED; Kurtin PG; Zent CS. "CD5+ B-cell lymphoproliferative disorders: Beyond chronic lymphocytic leukemia and mantle cell lymphoma". Leuk Res. 2010; 34(9): 1235-8.
2010 Jul
Shanafelt, TD; Rabe, KG; Kay, NE; Zent, CS; Call, TG; Slager, SL; Bowen, DA; Schwager, SM; Nowakowski, GS. "Statin and non-steroidal anti-inflammatory drug use in relation to clinical outcome among patients with Rai stage 0 chornic lymphocytic leukemia". Leuk Lymphoma. 2010; 51(7): 1233-40.
2010 Jul
Zent CS. "Chronic Lymphocytic Leukemia in the Elderly: Who Should be Treated?". Am Soc Clin Oncol Ed. 2010; : 268-71.
2010 Jun
Bauer PR; Zent CS; Aubry MC; Ryu JH. "Recurrent fevers, cough, and pulmonary opacities in a middle-aged man". Chest. 2010; 137(6): 1465-9.
2010 May
Zent CS; LaPlant BR; Johnston PB; Call TG; Habermann TM; Micallef IN; Witzig TE. "The treatment of recurrent/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) with everolimus results in clinical responses and mobilization of CLL cells into the circulation". Cancer. 2010; 116(9): 2201-7.
2010 May
Kay NE; Wu W; Kabat B; LaPlant B; Lin TS; Byrd JC; Jelinek DF; Grever MR; Zent CS; Call TG; Shanafelt TD. "Pentostatin and rituximab therapy for previously untreated patients with B-cell chronic lymphocytic leukemia". Cancer. 2010; 116(9): 2180-7.
2010 May
Zent CS. "Time to test CLL p53 function". Blood. 2010; 115(21): 4154-5.
2010 Apr
Bowen DA; Call TG; Shanafelt TD; Kay NE; Schwager RM; Reinalda MS; Rabe KG; Slager SL; Zent CS. "Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisone". Leuk Lymphoma. 2010; 51(4): 620-7.
2010 Mar
Zent CS; Kay NE. "Autoimmune complications in chronic lymphocytic leukaemia (CLL)". Best Pract Res Clin Haematol. 2010; 23(1): 47-59.
2010 Feb
Van Dyke DL; Shanafelt TD; Call TG; Zent CS; Smoley SA; Rabe KG; Schwager SM; Sonbert JC; Slager SL; Kay NE. "A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia". Br J Haematol. 2010; 148(4): 544-50.
2010 Feb
Zent CS; Van Dyke DL. "Detection of recurrent chromosomal defects in chronic lymphocytic leukemia/small lymphocytic lymphoma: innovations and applications". Leuk Lymphoma. 2010; 51(2): 186-7.
2010
Shanafelt TD, Rabe K; Kay NE; Zent CS; Jelinek DF; Reinala M; Schwager S; Dowen D; Slager SL; Hanson CA; Call TG. "Influence of age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia". Cancer. 2010; 116(20): 4777-87.
2010
Dronca RS; Jevremovic D; Hanson CA; Rabe KG; Shanafelt TD; Morice WG; Call TG; Kay NE; Collins CS; Schwager SM; Slager SL; Zent CS. "CD5-positive chronic B-cell lymphoproliferative disorders: diagnosis and prognosis of a heterogeneous disease entity". Cytometry B Clin Cytom. 2010; 58(Suppl 1): S35-41.
2009 Nov
Ding W; Nowakowski GS; Knox TR; Boysen JC; Maas ML; Schwager SM; Wu W; Wellik LE; Dietz AB; Ghosh AK; Secreto CR; Medina KL; Shanafelt TD; Zent CS; Call TG; Kay NE. "Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression". Br J Haematol. 2009; 147(4): 471-83.
2009 Sep
Shanafelt TD; Byrd JC; LaPlant B; Zent CS; Call T; Secreto C; Grever MR; Lin TS; Kay NE. "Pretreatment angiogenic cytokines predict response to chemoimmunotherapy in patients with chronic lymphocytic leukaemia". Br J Haematol. 2009; 146(6): 660-4.
2009 Aug
Zent CS; Ding W; Reinalda MS; Schwager SM; Hoyer JD; Bowen DA; Jelinek DF; Tschumper RC; Call TG; Shanafelt TD; Kay NE; Slager SL. "Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis". Leuk Lymphoma. 2009; 50(8): 1261-8.
2009 Aug
Shanafelt TD; Call TG; Zent CS; LaPlant B; Bowen DA; Roos M; Secreto CR; Ghosh AK; Kabat BF; Lee MJ; Yang CS; Jelinek DF; Erlichman C; Kay NE. "Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia". J Clin Oncol. 2009; 27(23): 3808-14.
2009 Aug
Shanafelt TD; Kay NE; Rabe KG; Call TG; Zent CS; Maddocks K; Jenkins G; Jelinek DF; Morice WG; Boysen J; Schwager S; Bowen D; Slager SL; Hanson CA. "Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia". J Clin Oncol. 2009; 27(24): 3959-63.
2009 Jun
Zent CS; Shanafelt T. "Management of autoimmune cytopenia complicating chronic lymphocytic leukemia". Leuk Lymphoma. 2009; 50(6): 863-4.
2009 Apr
Nowakowski GS; Hoyer JD; Shanafelt TD; Zent CS; Call TG; Bone ND; Laplant B; Dewald GW; Tschumper RC; Jelinek DF; Witzig TE; Kay NE. "Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemia". J Clin Oncol. 2009; 27(11): 1844-9.
2009 Apr
Shanafelt TD; Kay NE; Jenkins G; Call TG; Zent CS; Jelinek DF; Morice WG; Boysen J; Zakko L; Schwager S; Slager SL; Hanson CA. "B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome". Blood. 2009; 113(18): 4188-96.
2009 Feb
Shanafelt TD; Bowen DA; Venkat C; Slager SL; Zent CS; Kay NE; Reinalda M; Tun H; Sloan JA; Call TG. "The physician-patient relationship and quality of life: lessons from chronic lymphocytic leukemia". Leuk Res. 2009; 33(2): 263-70.
2009 Jan
Awan FT; Kay NE; Davis ME; Wu W; Geyer SM; Leung N; Jelinek DF; Tschumper RC; Secreto CR; Lin TS; Grever MR; Shanafelt TD; Zent CS; Call TG; Heerema NA; Lozanski G; Byrd JC; Lucas DM. "Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximab". Blood. 2009; 113(3): 535-537.
2009 Jan
Shanafelt TD; Jenkins G; Call TG; Zent CS; Slager S; Bowen DA; Schwager S; Hanson CA; Jelinek DF; Kay NE. "Validation of a new prognostic index for patients with chronic lymphocytic leukemia". Cancer. 2009; 115(2): 363-72.
2009
Pardanani A; Tefferi A; Litzow MR; Zent C; Hogan WJ; McClure RF; Viswanatha D;. "Chronic myeloid leukemia with p190BCR-ABL; prevalence, morphology, tyrosine kinase inhibitor response, and kinase domain mutation analysis". 2009; 114(16): 3502-3503.
2008 Dec
Zent CS; Secreto CR; LaPlant BR; Bone ND; Call TG; Shanafelt TD; Jelinek DF; Tschumper RC; Kay NE. "Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early-intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximab". Leuk Res. 2008; 32(12): 1849-56.
2008 Oct
Zent CS; Call TG' Shanafelt TD; Tschumper RC; Jelinek DF; Bowen DA; Secreto CR; Laplant BR; Kabat BF; Kay NE. "Early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab". Cancer. 2008; 113(8): 2110-8.
2008 Sep
Shanafelt TD; Kay NE; Cell TG; Zent CS; Jelinek DF; LaPlant B; Morice WG; Hanson CA. "MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count , greater than or equal to 5 x 10e9/L but a B-cell lymphocyte count less than or equal to 5 x 10e9/L?". Leuk Res. 2008; 32(9): 1458-61.
2008 Aug
Holtan SG; Porrata LF; Colgan JP; Zent CS; Habermann TM; Markovic SN. "mTOR inhibitor monotherapy is insufficient to suppress viremia and disease progression in Epstein-Barr virus-driven lymphoproliferative disorders (EBV-LPD)". Am J Hematol. 2008; 83(8): 688-9.
2008 May
Palmer S; Hanson CA; Zent CS; Porrata LF; Laplant B; Geyer SM; Markovic SN; Call TG; Bowen DA; Jelinek DF; Kay NE; Shanafelt TD. "Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia". Br J Haematol. 2008; 141(5): 607-14.
2008 May
Hogan WJ; Zent CS. "Stem cell transplant for chronic lymphocytic leukemia/small lymphocytic lymphoma". Leuk Lymphoma. 2008; 49(5): 835-6.
2008 May
Zent CS; Ding W; Schwager SM; Reinalda MS; Hoyer JD; Jelinek DF; Tschumper RC; Bowen DA; Call TG; Shanafelt TD; Kay NE; Slager SL. "The prognostic significant of cytopenia in chronoc lymphocytic leukaemia/small lymphocytic lymphoma". Br J Haematol. 2008; 141(5): 615-21.
2008 Mar
Shanafelt TD; Geyer SM; Bone ND; Tschumper RC; Witzig TE; Nowakowski GS; Zent CS; Call TG; Laplant B; Dewald GW; Jelinek DF; Kay NE. "CD49d expression is an independent predictor of overall survival i npatients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential". Br J Haematol. 2008; 140(5): 537-46.
2008 Feb
Zent CS. "The role of alemtuzumab in the treatment of chronic lymphocytic leukemia". Leuk Lymphoma. 2008; 49(2): 175-6.
2008 Jan
Thurmes P; Call T; Slager S; Zent C; Jenkins, G; Schwager S; Bowen, D; Kay NE; Shanafelt T. "Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia". Leuk Lymphoma. 2008; 49(1): 49-56.
2008 Jan
Tschumper RC; Geyer SM; Campbell ME; Kay NE; Shanafelt TD; Zent CS; Nowakowski GS; Call TG; Dewald GW; Jelinek DF. "Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients". J Clin Invest. 2008; 118(1): 306-15.
2007 Dec
Bowen DA; Call TG; Jenkins GD; Zent CS; Schwager SM; Van Dyke DL; Jelinek DF; Kay NE; Shanafelt TD. "Methylprednisolone-rituximab is an effective salvage therapy for patients with relapsed chronic lymphocytic leukemia including those with unfavorable cytogenetic features". Leuk Lymphoma. 2007; 48(12): 2412-7.
2007 Dec
Browning RL; Geyer SM; Johnson AJ; Jelinek DF; Tschumper RC; Call TG; Shanafelt TD; Zent CS; Bone ND; Dewald GW; Lin TS; Heerema NA; Gever MR; Kay NE; Byrd JC; Lucas DM. "Expression of TCL-1 as a potential prognostic factor for treatment outcome in B-cell chronic lymphocytic leukemia". Leuk Res. 2007; 49(1): 49-56.
2007 Nov
Maddocks-Christianson K; Slager SL; Zent CS; Reinalda M; Call TG; Habermann TM; Bowen DA; Hoyer JD; Schwager S; Jelinek DF; Kay NE; Shanafelt TD. "Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia". Br J Haematol. 2007; 139(3): 398-404.
2007 Oct
Shanafelt TD; Bowen D; Venkat C; Slager SL; Zent CS; Kay NE; Reinalda M; Sloan JA; Call TG. "Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients". Br J Haematol. 2007; 139(2): 255-64.
2007 Sep
Zent CS; Kay NE. "Chronic lymphocytic leukemia: biology and current treatment". Curr Oncol Rep. 2007; 9(5): 345-52.
2007 Jun
Shanafelt TD; Lin T; Geyer SM; Zent CS; Leung N; Kabat B; Bowen D; Grever MR; Byrd JC; Kay NE. "Pentostatin, cyclophosphamide, and rituximab regimen in older patients with chronic lymphocytic leukemia". Cancer. 2007; 109(11): 2291-8.
2007 Apr
Ding W; Zent CS. "Diagnosis and management of autoimmune complications of chronic lymphocytic leukemia/small lymphocytic lymphoma". Clin Adv Hematol Oncol. 2007; 5(4): 257-61.
2007 Apr
Nowakowski GS; Hoyer JD; Shanafelt, TD; Geyer, SM; LaPlant BR; Call TG; Jelinek DF; Zent CS; Kay NE. "Using smudge cells on routine blood smears to predict clinical outcome in chronic lymphocytic leukemia: a universally available prognostic test". Mayo Clin Proc. 2007; 82(4): 449-53.
2007 Feb
Rockacy J; Viozzi CF; Zent CS. "Mantle cell lymphoma presenting as a slowly enlarging lesion of the floor of mouth in a healthy 72 year old: report of a case". J Oral Maxillofac Surg. 2007; 65(2): 333-7.
2007 Jan
Kay NE; Geyer SM; Call TG; Shanafelt TD; Zent CS; Jelinek DF; Tschumper R; Bone ND; Dewald GW; Lin TS; Heerema NA; Smith L; Grever MR; Byrd JC. "Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemia". Blood. 2007; 109(2): 405-11.
2006 Dec
Zent CS; Polliack A. "Staging chronic lymphocytic leukemia (CLL) for prognosis at diagnosis". Leuk Lymphoma. 2006; 47(12): 2433-4.
2006 Oct
Zent CS. "Chronic B-cell lymphoproliferative disorders: how many diseases?". Leuk Lymphoma. 2006; 47(10): 2006-7.
2006 Oct
Shanafelt TD; Witzig TE; Fink SR; Jenkins RB; Paternoster SF; Smoley SA; Stockero KJ; Nast DM; Flynn HC; Tschumper RC; Geyer S; Zent CS; Call TG; Jelinek DF; Kay NE. "Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia". J Clin Oncol. 2006; 24(28): 4634-41.
2006 Sep
Lee HB; Pulido JS; Buettner H; Salomao D; Zent CS; Link TP. "Intravascular B-cell lymphoma (angiotropic lymphoma) with choroidal involvement". Arch Ophthalmol. 2006; 124(9): 1357-9.
2006 Sep
Zent CS; Call TG; Hogan WJ; Shanafelt TD; Kay NE. "Update on risk-stratified management for chronic lymphocytic leukemia". Leuk Lymphoma. 2006; 47(9): 1738-46.
2006 Sep
Shanafelt TD; Byrd JC; Call TG; Zent CS; Kay NE. "Narrative review: initial management for chronic lymphocytic leukemia". Ann Intern Med. 2006; 145(6): 435-47.
2006 Aug
Nora EH; Hamacher KL; Zent CS; Ghosh AK. "Indolent systemic mastocytosis as the cause of a long history of unexplained hypotensive episodes". South Med J. 2006; 99(8): 876-9.
2006 Aug
Zent CS. "Autoimmunity and chronic lymphocytic leukemia". Leuk Lymphoma. 2006; 47(8): 1443-4.
2006 Jul
Osborn NK; Ustundag Y; Zent CS; Wiesner RH; Rosen CB; Narayanan Menon KV. "Factor XII deficiency acquired by orthotopic liver transplantation: case report and review of the literature". Am J Transplant. 2006; 6(7): 1743-5.
2006 Jun
Fink SR; Smoley SA; Stockero KJ; Paternoster SF; Thorland EC; Van Dyke DL; Shanafelt TD; Zent CS; Call TG; Kay NE; Dewald GW. "Loss of TP53 due to rearrangements involving chromosome region 17p10 approximately p12 in chronic lymphocytic leukemia". Cancer Genet Cytogenet. 2006; 167(2): 177-81.
2006 Apr
Stockero KJ; Fink SR; Smoley SA; Paternoster SF; Shanafelt TD; Call TG; Zent CS; Van Dyke DL; Kay NE; Dewald GW. "Metaphase cells with normal G-bands have cryptic interstitial deletions in 13q14 detectable by fluorescence in situ hybridization in B-cell chronic lymphocytic leukemia". Cancer Genet Cytogenet. 2006; 166(2): 152-6.
2005 Dec
Shanafelt TD; Lee YK; Call TG; Nowakowski GS; Dingli D; Zent CS; Kay NE. "Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies". Leuk Res. 2005; 30(6): 707-12.
2005 Jul
Nowakowski GS; Dewald GW; Hoyer JD; Paternoster SF; Stockero KJ; Fink SR; Smoley SA; Remstein ED; Phyliky RL; Call TG; Shanafelt TD; Kay NE; Zent CS. "Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia". Br J Haematol. 2005; 130(1): 36-42.
2005 Jan
Nowakowski GS, Call TG; Morice WG; Kurtin PJ; Cook RJ; Zent CS. "Clinical significance of monoclonal B cells in cerebrospinal fluid". Cytometry B Clin Cytom. 2005; 63(1): 23-7.
2004 Sep
Zent CS; Kay NE. "Advances in the understanding of biology and prognosis in chronic lymphocytic leukemia". Curr Oncol Rep. 2004; 6(5): 348-54.
2004 May
Zent CS; Chen JB; Kurten RC; Kaushal GP; Lacy HM; Schichman SA. "Alemtuzumab (CAMPATH 1H) does not kill chronic lymphocytic leukemia cells in serum free medium". Leuk Res. 2004; 28(5): 495-507.
2004 Mar
Kyasa MJ; Hazlett L; Parrish RS; Schichman SA; Zent CS. "Veterans with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) have a markedly increased rate of second malignancy, which is the most common cause of death". Leuk Lymphoma. 2004; 45(3): 507-13.
2004 Feb
Zent CS; Kay NE. "Update on monoclonal antibody therapy in chronic lymphocytic leukemia". Clin Adv Hematol Oncol. 2004; 2(2): 107-13.
2004
Kohli M; Zent C; Hutchins LF; Safar M; Dotson P; Mehta P. "The academic hematology-oncology firm: a model for postgraduate cancer education". J Cancer Educ. 2004; 19(1): 45-9.
2003 Sep
Kyasa MJ; Parrish RS; Schichman SA; Zent CS. "Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma". Am J Hematol. 2003; 74(1): 1-8.
2003 Sep
Zent CS; Zhan FG; Schichman SA; Bumm KHW; Lin P; Chen JB; Shaughnessy JD. "The distinct gene expression profiles of chronic lymphocytic leukemia and multiple myeloma suggest different anti-apoptotic mechanisms but predict only some differences in phenotype". Leuk Res. 2003; 27(9): 765-74.
2002 Jan
Kohli M; Fink LM; Spencer JH; Zent CS. "Advanced prostate cancer activates coagulation: a controlled study of activation markers of coagulation in ambulatory patients with localized and advanced prostate cancer". Blood Coagul Fibrinolysis. 2002; 13(1): 1-5.
2002
Monson T; Schichman SA; Zent CS. "Linezolid-induced pure red blood cell aplasia". Clin Infect Dis. 2002; 35(3): E29-31.
2001 Dec
Joseph L; Scott MA; Schichman SA; Zent CS. "Localized herpes simplex lymphadenitis mimicking large-cell (Richter's) transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma". Am J Hematol. 2001; 68(4): 287-91.
2001
Zent C. "Anemia and chronic disease". US Medicine. 2001; 37(5 Suppl): 5-8.
2001
Zent CS; Kyasa MJ; Evans R; Schichman SA. "Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data". Cancer. 2001; 92(5): 1325-30.
2000 May
Kohli M; Schichman SA; Fink L; Zent CS. "Use of HFE mutation analysis for hereditary hemochromatosis: the need for physician education in the translation of basic science to clinical practice". South Med J. 2000; 93(5): 469-71.
1999 Oct
Govindarajan R; Baxter D; Wilson C; Zent C. "Vancomycin-induced thrombocytopenia". Am J Hematol. 1999; 62(2): 122-3.
1999 May
Zent CS; Ratajczak J; Ratajczak MZ; Anastasi J; Hoffman PC; Gewirtz AM. "Relationship between megakaryoctye mass and serum thrombopoietin levels as revealed by a case of cyclic amegakaryocytic thrombocytopenic purpura". Br J Haematol. 1999; 105(2): 452-8.
1998
Zent CS; Wilson CS; Tricot G; Jagannath S; Siegel D; Desikan KR; Munshi N; Bracy D; Barlogie B; Butch AW. "Oligoclonal protein bands and Ig isotype switching in multiple myeloma treated with high-dose therapy and hematopoietic cell transplantation". Blood. 1998; 91(9): 3518-23.
1997 Apr
Zent C; Rowley JD; Nucifora G. "Rearrangements of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: in vitro and in vivo studies". Leukemia. 1997; 3(11 Suppl): 273-8.
1996
Zent C; Kim N; Hiebert S; Zhang DE; Tenen DG; Rowley JD; Nucifora G. "Rearrangement of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: expression nof co-existing multiple chimeric genes with similar functions as transcriptional repressors, but with opposite tumorigneic properties". Current Topics in Microbiology & Immunology. 1996; 211: 243-52.
1996
Zent CS; Mathieu C; Claxton DF; Zhang DE; Tenen DG; Rowley JD; Nucifora G. "The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter properties". Proc Natl Acad Sci. 1996; 93(3): 1044-8.
1994 May
Zent C, Smith P. "Drug allergy". S AFr Med J. 1994; 84(5): 281-286.
1994
Zent CS. "Toxicity of anti-tuberculous medication". S. Afr J of Epidemiology and Infection. 1994; 9(1): 5-9.
1993 Nov
Zent CS, Allin R, Folb PI. "Prediction of amikacin dose requirements in neutropenic patients with haematological disease". S. Afr Med J. 1993; 82(11): 853-854.

Books

2010
Mauermann ML, Zent CS, Low PA. "Chronic lymphocytic leukemia causing multiple mononeuropathies". Companion to Peripheral Neuropathy: Illustrated Cases and New Developments. Dyck PJ, et.al.. Philadelphia: Saunders/Elsevier, 2010. 253-255
2010
Zent C and Polliack A. "Disorders of the Blood". Textbook of Medicine. Warrel D, Cox T, Firth J. : Oxford, 2010.
1997
Zent CS and Golomb HM. "Treatment options for hairy cell leukemia". Interferons: biological activities and clinical efficacy. Aul C, Schneider W. Berlin: Springer, 1997. 132-138
1996
Zent CS, Larson RA. "Acute leukmia in adults". The Chemotherapy Source Book. Perry MC. Baltimore, MD: Williams and Wilkins, 1996. 1379-1398
1995
Zent CS, Golomb HM. "Hairy Cell Leukemia". Current Therapy in Hematology-Oncology. Brain MC, Carbone PP. St. Louis, MO: Mosby, 1995. 271-274
1995
Zent CS. "Anti-infectives for systemic use". South African National Formulary. Gibbon CJ, Swanepoel CR. Cape Town: MASA, 1995. 224-277